导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.37% | 470/1050 |
| 近一周 | -2.14% | 464/1104 |
| 近一月 | -3.88% | 477/1102 |
| 近一季 | -7.20% | 536/1092 |
| 近半年 | -5.79% | 642/1070 |
| 近一年 | 8.04% | 387/1018 |
| 近两年 | 64.85% | 395/926 |
| 近三年 | 32.06% | 376/834 |
| 成立以来 | 138.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.05% 414/1070 |
15.92% 433/1101 |
- - |
- - |
| 2025 | 33.60% 419/1065 |
3.84% 490/1014 |
3.16% 424/1038 |
22.48% 523/1050 |
1.83% 322/1065 |
| 2024 | 1.22% 547/1011 |
-3.70% 515/960 |
-3.06% 508/983 |
11.76% 475/991 |
-2.99% 536/1011 |
| 2023 | -5.73% 220/952 |
5.71% 274/880 |
-3.56% 421/895 |
-3.38% 226/915 |
-4.29% 431/952 |
| 2022 | -12.27% 123/867 |
-7.79% 64/773 |
8.75% 311/806 |
-12.01% 391/845 |
-0.58% 468/867 |
| 2021 | 23.80% 126/740 |
4.49% 53/580 |
11.98% 312/659 |
3.19% 159/704 |
2.54% 330/740 |
| 2020 | 36.26% 322/554 |
-0.69% 179/419 |
20.21% 282/466 |
9.52% 261/517 |
4.22% 452/554 |
| 2019 | 43.69% 195/410 |
31.19% 307/1146 |
-4.91% 705/1228 |
5.65% 190/390 |
9.01% 190/410 |
| 2018 | -27.01% 177/349 |
- - |
-11.92% 592/990 |
-6.61% 545/1000 |
-9.21% 235/1080 |
| 2017 | 2.88% 166/285 |
- - |
- - |
- - |
- - |
| 2016 | 7.06% 11/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 嘉实量化精选股票 VS. 东吴新产业精选股票A(580008) |